Giordano Savelli
Giordano Savelli
Fondazione Poliambulaza Istituto Ospedaliero
Verified email at - Homepage
TitleCited byYear
Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions
G Savelli, L Maffioli, M Maccauro, E De Deckere, E Bombardieri
QJ Nucl Med 45 (1), 27-37, 2001
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours
A Chiti, S Fanti, G Savelli, A Romeo, B Bellanova, M Rodari, ...
European journal of nuclear medicine 25 (10), 1396-1403, 1998
Nuclear medicine imaging of neuroendocrine tumours
E Bombardieri, M Maccauro, E De Deckere, G Savelli, A Chiti
Annals of Oncology 12 (suppl_2), S51-S61, 2001
F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level
F Bertagna, G Bosio, G Biasiotto, C Rodella, E Puta, S Gabanelli, ...
Clinical nuclear medicine 34 (11), 756-761, 2009
The Role of Bone SPET Study in Diagnosis of Single Vertebral
G Savelli, A CHIT, G GRAssELLI, M Maccauro
Anticancer research 20, 1115-1120, 2000
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT
A Chiti, LS Maffioli, M Infante, G Grasselli, M Incarbone, MD Gasparini, ...
Journal of Nuclear Medicine 37 (6), 938-942, 1996
IQ SPECT allows a significant reduction in administered dose and acquisition time for myocardial perfusion imaging: evidence from a phantom study
F Caobelli, SR Kaiser, JT Thackeray, FM Bengel, M Chieregato, ...
Journal of Nuclear Medicine 55 (12), 2064-2070, 2014
Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours
G Savelli, G Lucignani, E Seregni, A Marchian˛, G Serafini, G Aliberti, ...
Nuclear medicine communications 25 (5), 445-449, 2004
Treatment options in hormone-refractory metastatic prostate carcinoma
A Fusi, G Procopio, SD Torre, R Ricotta, G Bianchini, R Salvioni, L Ferrari, ...
Tumori Journal 90 (6), 535-546, 2004
Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography
A Chiti, R Agresti, LS Maffioli, G Tomasic, G Savelli, F Crippa, S Pilotti, ...
European journal of nuclear medicine 24 (2), 192-196, 1997
Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review
L Nisa, G Savelli, R Giubbini
Annals of nuclear medicine 25 (2), 75-85, 2011
FDG–PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study
E Lopci, I Santi, E Derenzini, C Fonti, G Savelli, F Bertagna, M Bell˛, ...
Annals of oncology 21 (9), 1877-1883, 2010
Somatostatin receptor scintigraphy for bronchial carcinoid follow-up
S Fanti, M Farsad, G Battista, F Monetti, GC Montini, A Chiti, G Savelli, ...
Clinical nuclear medicine 28 (7), 548-552, 2003
Targeting VEGF-VEGFR pathway by sunitinib in peripheral primitive neuroectodermal tumor, paraganglioma and epithelioid hemangioendothelioma: three case reports
T Prochilo, G Savelli, P Bertocchi, C Abeni, L Rota, A Rizzi, A Zaniboni
Case reports in oncology 6 (1), 90-97, 2013
Gallium-67 as a tumor-seeking agent in lymphomas-a review
A Draisma, L Maffioli, M Gasparini, G Savelli, E Pauwels, E Bombardieri
Tumori Journal 84 (4), 434-441, 1998
Gemcitabine plus nab-paclitaxel as second-line and beyond treatment for metastatic pancreatic cancer: a single institution retrospective analysis
P Bertocchi, C Abeni, F Meriggi, L Rota, A Rizzi, B Di Biasi, F Aroldi, ...
Reviews on recent clinical trials 10 (2), 142-145, 2015
The importance of a correct positioning of the heart using IQ-SPECT system with multifocal collimators in myocardial perfusion imaging: a phantom study
F Caobelli, SR Kaiser, JT Thackeray, FM Bengel, M Chieregato, ...
Journal of Nuclear Cardiology 22 (1), 57-65, 2015
Residual brain viability, evaluated by 99mTc-ECD SPECT, in patients with suspected brain death and with confounding clinical factors
F Bertagna, O Barozzi, E Puta, S Lucchini, B Paghera, G Savelli, ...
Nuclear medicine communications 30 (10), 815-821, 2009
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y‐DOTA‐D‐Phe1‐Tyr3 octreotide
G Savelli, F Bertagna, F Franco, L Dognini, G Bosio, E Migliorati, ...
Cancer 118 (11), 2915-2924, 2012
The role of radionuclide therapy in medullary thyroid cancer
MR Castellani, A Alessi, G Savelli, E Bombardieri
Tumori Journal 89 (5), 560-562, 2003
The system can't perform the operation now. Try again later.
Articles 1–20